Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus paravertebral nerve block for ultra-fast-track pediatric cardiac anesthesia
ChiCTR2000030299Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, ropivacaine and Normal Saline-Benha University in Cardiovascular Malformation (CVM) (3 arms), sponsored by Guangzhou Women and Children's Medical Center. Primary endpoints: Sufentanil dose and Extubation time. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacaineNormal Saline-Benha University
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR2000030299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030299.